Get the Stockscreener App
12.49
4.00%
0.48
After Hours:
12.49
Replimune Group Inc Stock (REPL) Forecast
The Replimune Group Inc (REPL) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $6.0585, representing a -51.49% decrease from the current price of $12.49. The highest analyst price target is $7.4822, and the lowest is $4.6348.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month REPL Price Target
Average 20.22
(+61.89% Upside)
Is Replimune Group Inc (REPL) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 50.53 | Neutral |
| STOCH(9,6) | 31.64 | Neutral |
| STOCHRSI(14) | 67.21 | Neutral |
| MACD(12,26) | -0.0539 | Sell |
| ADX(14) | 18.40 | Neutral |
| William %R | -47.79 | Neutral |
| CCI(14) | -24.67 | Neutral |
Buy: 0
Sell: 1
Neutral: 6
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
12.33
Buy
|
12.34
Buy
|
| MA20 |
13.00
Sell
|
12.46
Buy
|
| MA50 |
12.20
Buy
|
12.16
Buy
|
| MA100 |
11.40
Buy
|
11.45
Buy
|
| MA200 |
9.5935
Buy
|
11.10
Buy
|
Buy: 9
Sell: 1
Neutral: 0
Summary: Buy
According to our latest analysis, REPL could be considered a Strong Buy, with 17 technical analysis indicators signaling 9 Buy signals, 2 signaling Sell signals and 6 Neutral signals. This might be a good time to open fresh positions on REPL, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 50.53 indicates that REPL is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 31.64 indicates that REPL is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 67.21 indicates that REPL is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 18.4 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -24.67 indicates that REPL is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term REPL price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Replimune Group Inc financial reports and earnings history, Replimune Group Inc (REPL) stock could reach $4.9533 by 2030, $3.367 by 2040 and $14.84 by 2050. See the projected annual prices until 2050 of the Replimune Group Inc stock below:
- Replimune Group Inc (REPL) is expected to reach an average price of $1.703 in 2035, with a high prediction of $6.226 and a low estimate of $1.103. This indicates an $-86.36% rise from the last recorded price of $12.49.
- Replimune Group Inc (REPL) stock is projected to chart a bullish course in 2040, with an average price target of $1.7951, representing an $-85.63% surge from its current level. The forecast ranges from a conservative $0.4631 to a sky-high $3.367.
- Our analysts predict Replimune Group Inc (REPL) to jump -59.18% by 2045, soaring from $5.6978 to an average price of $5.0978, potentially reaching $5.8972. While $5.6978 is the low estimate, the potential upside is significant.
- Replimune Group Inc (REPL) stock is expected to climb by 2050, reaching an average of $14.65, a $17.32% jump from its current level. However, a wide range of estimates exists, with high and low targets of $14.84 and $15.49, respectively, highlighting the market's uncertainty.
Replimune Group Inc Stock (REPL) Year by Year Forecast
Replimune Group Inc Stock (REPL) Price Forecast for 2025
Replimune Group Inc Stock (REPL) is expected to reach an average price of $20.22 in 2025, with a high prediction of $40.24 and a low estimate of $0.2036. This indicates an +61.89% rise from the last recorded price of $12.49.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $6.2095 | $4.6348 | $7.4822 | -50.28% |
| February, 2025 | $7.3642 | $6.2682 | $11.12 | -41.04% |
| March, 2025 | $4.7139 | $4.5289 | $10.57 | -62.26% |
| April, 2025 | $1.3022 | $0.2036 | $6.6575 | -89.57% |
| May, 2025 | $3.6769 | $0.9609 | $4.6982 | -70.56% |
| June, 2025 | $12.06 | $3.4856 | $13.25 | -3.43% |
| July, 2025 | $13.57 | $9.3687 | $17.03 | +8.69% |
| August, 2025 | $14.11 | $12.48 | $18.14 | +12.97% |
| September, 2025 | $15.78 | $10.42 | $16.48 | +26.38% |
| October, 2025 | $15.15 | $13.93 | $19.80 | +21.28% |
| November, 2025 | $15.22 | $12.58 | $19.38 | +21.88% |
| December, 2025 | $34.11 | $14.23 | $40.24 | +173.06% |
Replimune Group Inc Stock (REPL) Price Forecast for 2026
The predicted value for Replimune Group Inc (REPL) in 2026 is set at an average of $34.01. Estimates vary from a peak of $47.20 to a trough of $20.81, indicating an +172.28% surge from the present price of $12.49.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $44.20 | $33.30 | $47.20 | +253.89% |
| February, 2026 | $32.31 | $32.16 | $47.20 | +158.65% |
| March, 2026 | $35.75 | $29.52 | $38.39 | +186.23% |
| April, 2026 | $30.53 | $27.79 | $39.20 | +144.46% |
| May, 2026 | $28.09 | $23.70 | $30.59 | +124.88% |
| June, 2026 | $22.83 | $21.76 | $28.60 | +82.81% |
| July, 2026 | $27.91 | $20.98 | $30.63 | +123.43% |
| August, 2026 | $26.93 | $23.22 | $32.49 | +115.62% |
| September, 2026 | $28.09 | $24.67 | $33.21 | +124.93% |
| October, 2026 | $25.66 | $23.27 | $30.07 | +105.43% |
| November, 2026 | $24.93 | $20.81 | $25.80 | +99.63% |
| December, 2026 | $22.94 | $22.29 | $27.20 | +83.64% |
Replimune Group Inc Stock (REPL) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Replimune Group Inc (REPL) is $18.18, with a high forecast of $29.35 and a low forecast of $7.0074. This indicates an +45.53% increase from the last price of $12.49.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $22.39 | $21.34 | $25.61 | +79.27% |
| February, 2027 | $27.67 | $21.84 | $29.35 | +121.51% |
| March, 2027 | $19.75 | $18.36 | $28.49 | +58.12% |
| April, 2027 | $17.45 | $15.71 | $24.46 | +39.74% |
| May, 2027 | $11.92 | $11.28 | $17.05 | -4.57% |
| June, 2027 | $9.1221 | $8.9121 | $12.95 | -26.97% |
| July, 2027 | $10.81 | $8.7457 | $11.38 | -13.48% |
| August, 2027 | $12.20 | $10.68 | $14.40 | -2.31% |
| September, 2027 | $8.9948 | $7.0074 | $12.65 | -27.98% |
| October, 2027 | $9.2695 | $7.9095 | $11.65 | -25.78% |
| November, 2027 | $15.29 | $9.4181 | $15.37 | +22.45% |
| December, 2027 | $14.51 | $12.55 | $15.85 | +16.15% |
Replimune Group Inc Stock (REPL) Price Forecast for 2028
In 2028, Replimune Group Inc (REPL) is projected to reach an average price of $16.87, with a high projection of $24.30 and a low estimate of $9.4362. This indicates an +35.06% rise from the last price of $12.49.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $13.17 | $12.80 | $15.42 | +5.46% |
| February, 2028 | $11.66 | $9.4362 | $13.66 | -6.67% |
| March, 2028 | $12.84 | $11.09 | $14.57 | +2.80% |
| April, 2028 | $14.54 | $11.88 | $15.85 | +16.45% |
| May, 2028 | $21.42 | $13.35 | $22.80 | +71.48% |
| June, 2028 | $22.15 | $19.67 | $23.38 | +77.37% |
| July, 2028 | $19.73 | $19.49 | $24.30 | +57.95% |
| August, 2028 | $13.54 | $13.23 | $20.16 | +8.41% |
| September, 2028 | $11.71 | $11.21 | $15.65 | -6.28% |
| October, 2028 | $12.50 | $10.49 | $13.17 | +0.08% |
| November, 2028 | $14.12 | $12.14 | $16.01 | +13.08% |
| December, 2028 | $18.43 | $15.16 | $19.98 | +47.55% |
Replimune Group Inc Stock (REPL) Price Forecast for 2029
The 2029 price forecast for Replimune Group Inc Stock (REPL) is $10.21 on average, with a high prediction of $18.83 and a low estimate of $1.6025. This represents an -18.22% decrease from the previous price of $12.49.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $16.37 | $14.72 | $18.83 | +31.08% |
| February, 2029 | $15.93 | $13.41 | $16.95 | +27.51% |
| March, 2029 | $13.34 | $13.09 | $16.72 | +6.81% |
| April, 2029 | $10.76 | $9.9458 | $13.59 | -13.88% |
| May, 2029 | $6.7292 | $6.3692 | $10.89 | -46.12% |
| June, 2029 | $7.4039 | $5.4465 | $7.9898 | -40.72% |
| July, 2029 | $4.1985 | $1.6025 | $8.0962 | -66.38% |
| August, 2029 | $3.6219 | $3.1746 | $5.3059 | -71.00% |
| September, 2029 | $4.1666 | $2.6492 | $4.3992 | -66.64% |
| October, 2029 | $4.2299 | $3.9099 | $5.2113 | -66.13% |
| November, 2029 | $2.5546 | $2.4346 | $4.5086 | -79.55% |
| December, 2029 | $2.83 | $1.9833 | $2.922 | -77.34% |
Replimune Group Inc Stock (REPL) Price Forecast for 2030
Replimune Group Inc Stock (REPL) is expected to reach an average price of $3.4609 in 2030, with a high forecast of $6.9128 and a low forecast of $0.00897. This signifies an -72.29% decrease from the last price of $12.49.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $5.8833 | $4.4453 | $4.9533 | -52.90% |
| February, 2030 | $5.2839 | $5.2763 | $4.9559 | -57.69% |
| March, 2030 | $5.6046 | $5.8606 | $5.1346 | -55.13% |
| April, 2030 | $7.3352 | $7.7902 | $6.8099 | -41.27% |
| May, 2030 | $3.8285 | $4.685 | $6.9128 | -69.35% |
| June, 2030 | $1.7591 | $3.8891 | $5.1138 | -85.92% |
| July, 2030 | $3.8774 | $0.6894 | $3.5724 | -68.96% |
| August, 2030 | $2.613 | $3.683 | $3.275 | -79.08% |
| September, 2030 | $0.6063 | $2.3137 | $2.016 | -95.15% |
| October, 2030 | $0.0431 | $0.00897 | $2.571 | -99.66% |
| November, 2030 | $6.1876 | $0.9096 | $3.5776 | -50.46% |
| December, 2030 | $6.9582 | $7.3782 | $6.3982 | -44.29% |
2.88%
2.65%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):